Pregnancy outcomes following exposure to onabotulinumtoxinA

PURPOSE: To evaluate pregnancy outcomes following onabotulinumtoxinA (US Food and Drug Administration pregnancy category C product) exposure using the Allergan safety database. METHODS: The Allergan Global Safety Database contains reports of onabotulinumtoxinA administration before/during pregnancy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Brin, Mitchell F., Kirby, Russell S., Slavotinek, Anne, Miller‐Messana, Mary Ann, Parker, Lori, Yushmanova, Irina, Yang, Huiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063122/
https://www.ncbi.nlm.nih.gov/pubmed/26635276
http://dx.doi.org/10.1002/pds.3920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063122/
https://www.ncbi.nlm.nih.gov/pubmed/26635276
http://dx.doi.org/10.1002/pds.3920

Ejemplares similares